In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification

抗体 亲和力成熟 细胞因子 生物 受体 体外 体细胞突变 免疫系统 免疫学 分子生物学 细胞生物学 B细胞 生物化学
作者
Stefan Steidl,Olaf Ratsch,Bodo Brocks,Manuela Dürr,Elisabeth Thomassen-Wolf
出处
期刊:Molecular Immunology [Elsevier]
卷期号:46 (1): 135-144 被引量:85
标识
DOI:10.1016/j.molimm.2008.07.013
摘要

The mammalian immune system applies somatic hypermutation to select for antibodies with improved dissociation rates in vivo up to an intrinsic limit, previously termed as affinity ceiling. However, for certain therapeutic applications it may be desirable to further improve antibody affinities beyond that limit. In this study the selection of antibodies specific for the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) from the HuCAL GOLD human antibody library is described. In order to increase affinity and also functional activity, in vitro affinity maturation of a pool of lead Fab candidates was carried out. CDR-L3 and parallel CDR-H2 diversification using trinucleotide consensus cassettes were followed by the combination of optimized CDR-L3 and CDR-H2 leading to a 5000-fold improved affinity finally reaching a KD of 400 fM. Cytokine neutralizing potential of MOR04357 was evaluated in a TF-1 proliferation assay. Along with affinity optimization a 2000-fold increase in potency was observed compared to the parental antibody. Due to species cross-reactivity MOR04357 also blocks rat GM-CSF induced proliferation of FDCP-1 cells. Receptor inhibition studies showed that MOR04357 prevents the interaction of GM-CSF with the GM-CSF receptor alpha chain. As a consequence this leads to a blockade in signal transduction as measured by abolished STAT5 phosphorylation in the presence of GM-CSF and antibody. Due to its pro-inflammatory role GM-CSF has been implicated in the pathophysiology of inflammatory diseases like rheumatoid arthritis or asthma. Based on the mode of action described herein MOR04357 shows favourable antibody features as a potential drug candidate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
111完成签到,获得积分10
2秒前
pengxu应助跳跳骑士采纳,获得10
3秒前
3秒前
gnwnb发布了新的文献求助10
5秒前
楼轶发布了新的文献求助10
7秒前
100完成签到,获得积分10
10秒前
小纸人完成签到,获得积分10
10秒前
的速度发布了新的文献求助10
10秒前
不倦应助jj采纳,获得10
11秒前
陈露发布了新的文献求助10
11秒前
Hello应助小李采纳,获得10
15秒前
爱笑的冷风完成签到 ,获得积分10
16秒前
ding应助骆一锅采纳,获得10
16秒前
wyr完成签到,获得积分0
16秒前
科研小白关注了科研通微信公众号
19秒前
公孙玲珑完成签到,获得积分10
21秒前
小二郎应助南庭采纳,获得10
21秒前
22秒前
的速度完成签到,获得积分10
22秒前
Chenzhs完成签到,获得积分10
23秒前
24秒前
科研通AI2S应助mbf采纳,获得10
24秒前
森林木发布了新的文献求助10
29秒前
youayou发布了新的文献求助10
29秒前
超帅蛋挞完成签到,获得积分10
30秒前
32秒前
32秒前
wentong完成签到,获得积分10
34秒前
37秒前
大模型应助hnututu采纳,获得10
37秒前
斯文败类应助hnututu采纳,获得10
37秒前
可爱的函函应助hnututu采纳,获得10
37秒前
李健应助hnututu采纳,获得10
37秒前
打打应助hnututu采纳,获得30
37秒前
我是老大应助hnututu采纳,获得30
37秒前
传奇3应助hnututu采纳,获得10
37秒前
酷波er应助活力夜白采纳,获得10
37秒前
希望天下0贩的0应助hnututu采纳,获得30
37秒前
小二郎应助hnututu采纳,获得10
37秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
安全防范技术与工程 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
2-Acetyl-1-pyrroline: an important aroma component of cooked rice 500
A real-time energy management strategy based on fuzzy control and ECMS for PHEVs 400
2024 Medicinal Chemistry Reviews 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3190987
求助须知:如何正确求助?哪些是违规求助? 2840243
关于积分的说明 8027571
捐赠科研通 2503538
什么是DOI,文献DOI怎么找? 1336962
科研通“疑难数据库(出版商)”最低求助积分说明 637981
邀请新用户注册赠送积分活动 606406